Eplerenone
Eplerenone is a selective mineralocorticoid receptor antagonist used to study the regulation of blood pressure and cardiac remodeling. Researchers utilize this API for its high affinity for aldosterone receptors with minimal androgenic interference.
Description
Comprehensive Product Overview
In the field of nephrology and cardiology, the selective inhibition of aldosterone binding to the mineralocorticoid receptor is vital for managing sodium retention and potassium homeostasis. Specifically, Eplerenone functions by competitively inhibiting the receptor, thereby reducing the expression of epithelial sodium channels (ENaC). Additionally, researchers select this molecule for its low affinity for progesterone and androgen receptors, which minimizes endocrine-related side effects in long-term studies. Therefore, whether you investigate the molecular triggers of left ventricular dysfunction or develop new anti-hypertensive protocols, this API delivers reliable pharmacological support across various laboratory conditions.
Zyntex maintains a transparent production chain to ensure a precise analytical profile for every batch, focusing on the limitation of related steroidal impurities. Moreover, our quality control team verifies every lot for polymorphic stability and particle size distribution to ensure consistent dissolution rates in formulation research. For instance, we optimize the purity to support the development of novel delivery systems aimed at improving the bioavailability of poorly water-soluble steroids. As a result, your lab receives a high-purity reagent for advanced studies into the attenuation of oxidative stress in the vascular endothelium.
Modern clinical science relies on high-quality mineralocorticoid antagonists to address the global burden of chronic heart failure and post-infarction complications. Because Eplerenone possesses a documented ability to reduce collagen deposition and improve arterial compliance, it remains a primary focus for studies involving tissue remodeling. Ultimately, Zyntex provides a dependable foundation for your next innovation in cardiovascular medicine and specialized pharmaceutical engineering.
Specialized Cardiovascular Applications
This high-selectivity receptor antagonist is vital for the following research and production sectors:
🫀 Cardiac Remodeling
Scientists use Eplerenone to study the inhibition of fibroblast proliferation and the stabilization of the myocardial matrix post-MI.
🩸 Hypertension Research
Researchers include this API in protocols focused on managing resistant hypertension and primary aldosteronism.
🧬 Endothelial Function
Biotechnicians utilize this molecule to study the reduction of inflammatory markers and the enhancement of nitric oxide bioavailability.
💊 Formulation Science
This compound serves as a core tool for engineering solid dosage forms and pediatric liquid suspensions with high chemical stability.
Technical Specifications
| Parameter | Specification Standard |
|---|---|
| Product Name | Eplerenone (CAS 107724-20-9) |
| Molecular Formula | C24H30O6 |
| Purity | USP / Ph. Eur. Grade (Min. 99%) |
| Appearance | White to off-white crystalline powder |
| Loss on Drying | < 0.5% |
🔬 Scientific Data: For detailed receptor binding assays, pharmacokinetic data, and metabolic pathway studies, consult: PubChem Entry: Eplerenone (External Link)
